The COVID-19 vaccine drill will take place on December 28 and 29. (Representative image) Chandigarh: The Center chose Punjab to conduct a COVID-19 vaccine trial on December 28 and 29, state Health Minister Balbir Singh Sidhu said on Thursday. “The districts of Ludhiana and Shaheed Bhagat Singh Nagar have been …
Read More »Coronavirus | Over 6,000 UK travelers tracked across all states
Passengers who tested positive were transferred to separate quarantine units. According to a Health Ministry directive, several states have stepped up their efforts to track and test people who have flown or transited from the UK between November 25 and December 23, in search of a more infectious version. of …
Read More »Covaxin triggered immune responses, with no serious adverse events: Bharat Biotech
Covaxin, a candidate for BHARAT BIOTECH’s indigenous Covid vaccine currently in late-stage clinical trials, triggered humoral and cell-mediated immune responses and was well tolerated with no serious adverse events in its phase 2 trials, according to an article by Research released by the Hyderabad-based company, which has yet to be …
Read More »The Covid-19 vaccine will be administered to 51 thousand inhabitants of Delhi in the first round: Kejriwal
Delhi’s Chief Minister Arvind Kejriwal today unveiled the state government’s mega Covid-19 vaccination plan. He said his government was prepared to receive, store and supply vaccines to priority category people in the city. He said there were 51 lakhs of people, including frontline and healthcare workers, who would receive the …
Read More »UK detects another infectious mutant variant of coronavirus and tightens lockdown
This new variant is concerning because it is more transmissible and has mutated more than the new variant that has been discovered in the UK, authorities said. In the UK, two cases of another new South African-related coronavirus have been identified, Health Secretary Matt Hancock revealed in London on Wednesday. …
Read More »COVID-19 Covaxin Vaccine Shows Long-Term Antibody Response, Says Bharat Biotech In Research Paper
Covaxin can generate antibodies that can persist for 6 to 12 months, Bharat Biotech said. (Archive) Hyderabad: Covaxin, a COVID-19 vaccine developed by Bharat Biotech, showed long-term memory responses of antibodies and T (immune) cells three months after injection in phase 1 volunteers and tolerable safety results in phase 2 …
Read More »Bharat Biotech has reapplied for Covid-19 vaccine emergency authorization, sources say
Hyderabad-based Bharat Biotech has applied for the Emergency Use Authorization of its COVID-19 COVAXIN vaccine again with the Comptroller General of Drugs of India (DCGI), sources told News18 on Wednesday. COVAXIN, an inactivated candidate vaccine, is currently in phase III human clinical trials with 26,000 volunteers at 25 centers in …
Read More »Antibodies generated by Covaxin can persist for 6-12 months: Bharat Biotech | India News
HYDERABAD: India’s first indigenous Covid-19 vaccine, Covaxin, has shown long-term antibody and T-cell memory responses three months after vaccination in phase I volunteers Covaxin can generate antibodies that can persist for 6 to 12 months, Bharat Biotech said in a research article. According to the document uploaded to ‘medRxiv’, a …
Read More »Rahul Gandhi mockery about the Covid vaccine
Rahul Gandhi said that 23 lakh people in the world have already received the Covid vaccine. Highlight Rahul Gandhi said 23 lakhs around the world have already received the vaccine. PM had said that Covid vaccines “will probably be ready in a few weeks” Only Bharat Biotech’s Covaxin is in …
Read More »China, US, UK and Russia have started vaccinating, says Rahul Gandhi, questions India’s progress
Congressional Leader Rahul Gandhi criticized Prime Minister Narendra Modi for failing to implement coronavirus vaccines in the country despite other countries starting their respective vaccination campaigns. “23 lakh people in the world have already received Covid vaccines. China, USA, UK, Russia have started. India ka number kab ayegaa, Modi ji? …
Read More »